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Endovascular treatment of iliac aneurysm:
Concurrent comparison of side branch endograft
versus hypogastric exclusion
Fabio Verzini, MD, Gianbattista Parlani, MD, Lydia Romano, MD, Paola De Rango, MD,
Giuseppe Panuccio, MD, and Piergiorgio Cao, MD, FRCS, Perugia, Italy
Objective: To analyze early and mid-term outcome of endovascular treatment in patients with iliac aneurysms, comparing
the results of hypogastric revascularization by branch endografting with those of hypogastric occlusion.
Methods: Consecutive patients with iliac aneurysms receiving side branch endograft (Group I) were compared with those
receiving endograft with hypogastric exclusion (Group II) during the interval from January 2000 to May 2008.
Procedural details and outcomes were prospectively collected and were analyzed at one year to avoid mismatch in
follow-up length.
Results: A total of 74 patients (mean age, 75.8 years, 95% males) were treated: 32 in Group I and 42 in Group II. No
differences in baseline risk factors and aneurysm diameter (40.2 7.9 mm in Group I vs. 38.4 10.8 in Group II) were
found. Concurrent treatment of aortic aneurysm was performed in 25/32 (78%) of Group I and 36/42 (86%) of Group
II. Fluoro time was 48 minutes (interquartile range [IQR] 31-57) in Group I vs. 31 minutes (IQR 23-38) in Group II
(P  .04). The amount of contrast was similar in both Groups: 184 ml (IQR 155-210) in Group I vs. 183 ml (IQR
155-200) in Group II. No intestinal ischemia or deaths occurred. There were no significant differences in failures of
hypogastric side branch deployment (2/32) compared with hypogastric coiling (3/42). Limb occlusions all occurring in
the external iliac artery side were 2/32 in Group I vs. 3/42 in Group II. Reintervention rates were similar (5/32 vs.
4/42) at one year. Shrinkage of 5 mm or more was detected in 7/23 (30%) of Group I and in 13/37 (34%) of Group II.
Iliac endoleak was present in eight patients (19%) in Group II and in one patient in Group I (4%) (P  .1). Similarly,
buttock claudication or impotence were more frequent after hypogastric exclusion, recorded in eight patients in Group
II and in one patient in Group I (P  .1).
Conclusions: Endovascular treatment of iliac aneurysm with hypogastric revascularization through side branched
endografts is feasible and safe in the mid-term. When compared with hypogastric embolization, this option leads to
similar technical success and reintervention rates. Endoleak and buttock claudication occur frequently in patients with
iliac aneurysm treated with hypogastric exclusion, while are uncommon in those with hypogastric revascularization. Side
branch endografting for iliac aneurysm may be considered a primary choice in younger, active patients with suitable
anatomy, but larger studies and longer postoperative observation periods are needed. (J Vasc Surg 2009;49:1154-61.)Unfavorable iliac anatomy is a major challenge in en-
dovascular abdominal aneurysm repair (EVAR). Dilation of
one or both common iliac arteries (CIA), making them
unsuitable for adequate distal sealing and therefore com-
promising the success of endovascular repair and the feasi-
bility of the procedure, may be present in up to 30% of
EVAR patients.1-4
To prevent type 2 endoleak, coil embolization of hy-
pogastric artery, followed by endograft extension into the
external iliac artery (EIA), is usually performed. The sacri-
fice of hypogastric artery may rarely result in severe mor-
bidity and mortality, caused by bowel or even spinal isch-
emia,4 particularly in the presence of bilateral hypogastric
occlusion and/or concomitant atherosclerotic occlusive
disease, while it does not definitely reduce the risk of type 2
endoleak.4 Repair with a bifurcated iliac endograft, the iliac
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1154side branch device (IBD) has recently emerged as an alter-
native, flow-preserving, endovascular technique to address
this problem. While a few recent series have demonstrated
the feasibility of this approach in preserving pelvic flow,
ensuring distal sealing during EVAR, they failed to contrast
this new technique to other contemporary endovascular
procedures for management of iliac aneurysms.5-9
The purpose of this study was to compare early and
1-year outcome of the IBD approach with that of hypogas-
tric embolization followed by endograft extension across
the iliac bifurcation, in a consecutive series of patients
treated for significant (24 mm) unilateral or bilateral iliac
aneurysms associated or not with aortic aneurysm. In par-
ticular, rates of pelvic ischemia, failure of aneurysm exclu-
sion, and need for reintervention were analyzed.
MATERIALS AND METHODS
All consecutive patients undergoing endovascular
treatment between January 2000 and May 2008 for iliac
aneurysm involving iliac bifurcation, associated or not with
abdominal aortic aneurysm (AAA) repair, were reviewed.
Pseudoaneurysms, symptomatic, and ruptured iliac aneu-
rysms, as well as iliac aneurysms managed with open repair
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bottom technique were excluded.
Iliac aneurysms were selected as either single or multi-
ple dilation with diameter larger than 24 mm, located
within the common, external, or hypogastric arteries, with-
out a suitable proximal and distal neck for sealing with
commercially available endovascular iliac endografts.
Patient characteristics, comorbidities, operative data,
intra-, and postoperative complications, were prospectively
gathered in a computed database.
After January 2006, patients considered candidates for
endograft repair and requiring coverage of one or both
hypogastric artery origins to obtain a distal seal, were
offered to IBD procedures using bifurcated iliac Zenith
endograft devices (William Cook, Bloomington, Ind),
when anatomical characteristics were suitable.
Patients receiving IBD (Group I) were compared with
those receiving the most traditional hypogastric coverage
and embolization, followedby extension of the endograft into
the EIA (Group II). Primary outcomes were: aneurysm-
related death (defined as any death occurring within 30 days
or within the same hospitalization from the original endovas-
cular or from any secondary procedure, any death caused by
the aneurysm or coming from graft complications), aneurysm
rupture, pelvic ischemia (bowel, spinal cord or nerve ischemia,
sexual impotence, buttock or thigh claudication, buttock ne-
crosis), failure to exclude iliac aneurysm (growth  5 mm in
maximum diameter, endoleak), and need for reintervention.
Secondary outcomes were: technical failure, defined as impos-
sibility to deploy the IBD, stent-grafts or coils in the intended
sites, newly occurring bilateral hypogastric occlusion at the
end of the procedure, and/or iliac graft or external iliac
occlusion, iliac patency, operative times, medium contrast
usage, and fluoroscopy times.
Patients were routinely interviewed for the new onset
of symptoms and signs indicative of bowel ischemia, leg
ischemia, or impotence after treatment. Bowel ischemia
was clinically suspected based on symptoms, physical exam-
ination, and chemical laboratory findings, and eventually
endoscopically documented and checked with laparotomy.
Buttock claudication was defined according to Intercon-
sensus standards and based on physical examination and
patients’ complaint.10 Echo-doppler with ankle-brachial
index (ABI) measurements were used to assess patency of
hypogastric, iliac, and femoral vessels. Impotence was as-
sessed by patient referred symptoms.
All patients underwent preoperative evaluation with
computed tomographic (CT) scanning with intravenous
contrast. Maximum intensity projections (MIP), thin axial
cuts, and 3D reconstruction using high magnification soft-
ware have been used to assess iliac dilation extension,
morphology, tortuosity, sizing, and to plan the repair.
Operative techniques. Intraoperative aortic angiog-
raphy with a marked catheter for appropriate length mea-
surements was commonly used. When an AAA was also
present, EVARwas performed usingmodular commercially
available endografts, selected according to anatomical char-
acteristics and operators preferences in case of hypogastricexclusion, or with a Zenith device (Cook Inc, Blooming-
ton, Ind) in case of IBD. A proximal and distal fixation zone
of 15 mm was usually required for endovascular repair to
obtain safe seal.
Those individuals presenting with bilateral iliac aneu-
rysm were treated with revascularization of at least one of
the two iliac sides when technically feasible, either with IBD
(Group I) or by means of external to internal iliac surgical
bypass (Group II).
IBD technique (Group I). IBD approach was used
with a suitable healthy segment of EIA to provide a distal
fixation zone of at least 15 mm length, in the absence of
excessive tortuosity associated with calcification that could
prevent delivery and deployment of the graft. A patent
lumen of the CIA of at least 20 mm in diameter and 40 mm
in length was required for correct graft expansion. A distal
landing zone of at least 10 mm length on the main hypo-
gastric trunk was required. In case of bilateral IIA aneurys-
mal involvement, the side with the most proximal healthy
segment, with richer distal arterial bed, without extensive
calcification or tortuosity (as evaluated on the preoperative
CT) was chosen for IBD placement. The other side was
excluded with coil embolization.
The device used is the version of the Zenith IBD (Cook
Inc) with a side, straight, short IIA branch, different from the
“spiral” IBD used in other published experiences.6 The IBD
was introduced through femoral access, either percutane-
ously or by small surgical cut down, over a stiff guidewire
(Lunderquist; Cook Inc) and oriented under fluoroscopic
guidance. After IBDdeployment, a covered stent (Advanta;
Atrium Medical, Hudson, NH, or Fluency; C.R. Bard Inc,
Murray Hill, NJ) was deployed to fill the gap between side
branch of the IBD and the hypogastric artery, to ensure
adequate sealing and patency.
In the presence of AAA, the procedure was completed
by placing the main bifurcated Zenith body and subse-
quently bridging the gap to the proximal portion of the
IBD with a Zenith limb extension (Fig 1).
Embolization technique (Group II). Coil emboliza-
tion (MR Eye Coils, Cook Inc) or occluder placement
(Amplatzer, AGA Medical Corp, Plymouth, Minn) of the
origin of the hypogastric artery was performed at the same
time as EVAR, to achieve an appropriate sealing in CIA
aneurysm without adequate distal neck (15 mm in
length). For aneurysms involving the hypogastric artery, its
primary branches were coil embolized. The origin of hypo-
gastric artery was then, during the same procedure, covered
with an endograft limb extending into the EIA.
In case of bilateral IIA aneurysmal involvement for the
group of patients without IBD placement, one side was
chosen for surgical revascularization based on anatomical
grounds (the one with the most proximal healthy segment,
with richer distal arterial bed, without extensive calcifica-
tion as evaluated on the preoperative CT). An oblique
incision over the inguinal ligament was performed and a
retroperitoneal approach was used. A bypass from the EIA,
distally to the previously deployed aorto-iliac endograft,
to the transected hypogastric artery with proximal over-
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diameter, sutured distally in an end-to-end fashion to the
IIA.
Follow-up. Follow-up protocol after repair included
physical examination, abdominal color Duplex ultrasound,
and plain abdominal radiography at one month and every
six months thereafter, while CT scan was repeated at one
month and yearly thereafter, to control aneurysm diameters
and the presence of any endoleak, graft occlusion, or com-
plications.
Statistical analysis. Categorical variables in Group I
and Group II were compared with the 2 or the Fischer
exact test, and means were compared using the Student t
test. P values  .05 were considered significant. To avoid
mismatch in the length of follow-up (since IBD was most
recently employed) only results at 12 months have been
evaluated in the analysis, therefore outcomes were com-
pared at 30 days (perioperative) and at one year. All the
analyses were performed using SPSS package, 13.0 version
(SPSS Inc, Chicago, Ill).
RESULTS
During the study period, a total of 74 patients (69 men)
with amean age of 75.6 years underwent iliac aneurysm repair
using IBD or hypogastric coverage and embolization. These
included 32 IBD repairs (Group I) occurring between 2006
and 2008, and 42 hypogastric embolizations with EIA en-
dograft extension (Group II).
Table I shows preoperative patient characteristics and
risk factors in Group I and Group II. There was a tendency
toward younger age and reduced cardiac risk in the IBD
Fig 1. Abdominal 3-D computerized tomography reconstruc-
tion after aorto-bi-iliac endografting with right iliac side branch,
showing patent graft, external, and internal iliac arteries.group compared with the IIA exclusion group, withoutsignificant differences. No patient presented buttock or
thigh claudication.
In most of the cases, iliac aneurysm was associated with
AAA (25 in Group I, 36 in Group II) and required con-
comitant EVAR repair.
In Group I, six aneurysms extended to IIA (19 %).
Group II showed a higher rate of IIA involvement (14
patients, 34%), with nine isolated IIA requiring treatment.
Incidence of IIA aneurysm between groups was not statis-
tically different (P  .2). There were no EIA aneurysms,
while a total of eight patients had bilateral iliac involvement
(Table II). The mean preoperative maximum iliac diameter
was 40.2  7.9 mm in Group I and 38.4  10.8 mm in
Group II (P  .4).
Operative details in Group I showed that 13 patients
have been operated by local, eight by epidural, and 11 by
general anesthesia; 13 patients had a percutaneous femoral
access pre-closed with a Prostar XL device (Abbott Vascu-
lar, Abbott Park, Ill). A bifurcated aorto-iliac endograft was
used in 26 patients, while six had only the IBD placed in
one iliac artery, without aortic graft. To bridge the gap
between the IBD and the distal IIA, a balloon expandable
graft, Advanta V12, was used in 19 patients (59%), five
required a second self expandable stent apposition distally
for sealing. In 13 patients (41%), a self expandable stent
(Fluency, C.R. Bard) was used, with a double stent-graft
needed in one case.
In Group II, 18 patients had general anesthesia, 14
patients had been operated under epidural, and eight under
local anesthesia. Regarding graft configurations, three pa-
tients had an aorto-uni-liac (AUI) graft (one Talent, one
Zenith, converted to AUI after impossibility to cannulate
the contralateral limb of a bifurcated device, one Endo-
med), five had an iliac tube graft (one Hemobhan, one
Excluder, one Talent, two Zenith), and 34 had an aortic
bifurcated device (one AneuRx, three Fortron, four Ex-
cluder, six Talent, and 20 Zenith). There were no peri-
operative deaths, myocardial infarctions, strokes, conver-
sion to open repair, mesenteric or spinal cord infarcts, or
buttock necrosis in either group. Major morbidity requir-
ing medical treatment in Group I occurred in three pa-
tients: one had an episode of atrial fibrillation requiring
medical treatment, one patient had asymptomatic pulmo-
nary embolism detected at the postoperative CT control,
and the third patient, with preoperative renal failure, had a
worsening of renal dysfunction requiring chronic dialysis.
In Group II, major morbidity occurred in four patients:
two required prolonged hospitalization for inguinal lym-
phorrea, one had clostridium difficilis pseudomembranous
colitis, and the fourth had embolic renal infarct medically
treated.
Technical success was 94% in the IBD Group and 93%
in the IIA embolization group (P  1). There were two
failures in Group I, both for intraoperative IIA occlusion.
One was due to thrombus shift into the IIA during cathe-
ters and guidewire manipulations inside the iliac aneurysm,
and the other due to impossibility to correctly deploy the
covered stent into the distal IIA landing zone for excessive
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patients with bilateral IIA occlusion: in one the EIA to IIA
by-pass occluded early and in the other EIA to IIA bypass
was not performed for extensive calcification. The third
failure was due to iliac aneurysm tortuosity and unfeasibility
to place the planned coils into the IIA. Therefore, for the
subgroup of four EIA to IIA surgical bypass performed to
obtain one side revascularization in bilateral iliac aneurysm
in Group II, technical success was 50%: one was not feasible
for vessel calcification, another occluded intraoperatively,
and the other two remained well patent and asymptomatic
during follow-up.
In the first 30 days postoperatively, two external iliac
limb occlusions occurred in each group for a limb primary
patency of 95% and 94%, respectively. Patency was restored
in two of the four patients by thrombectomy and stent.
Distal revascularization was achieved with femoro-femoral
cross over bypass in a third patient, while in the fourth
(Group II) non- limiting symptoms required no surgical
treatment.
Early reintervention was required in five patients in the
IBD group (16%): two patients underwent thrombectomy,
one, with known bleeding disorder, underwent a femoral
revision for bleeding after percutaneous access. Another
patient, who underwent femoral artery repair for pseudoan-
eruysm at the access site, had a type 1 distal endoleak at the
distal IIA sealing zone requiring a secondary IIA stent-
grafting. The fifth patient with a type 3 endoleak between
Table I. Risk factors in 74 patients
Group I  32
N
Male gender 30 9
Mean age (yrs) 73.6  8.3
Smoking 18 5
Hypertension 29 9
Diabetes 3
Hypercholesterolemia 9 2
Coronary artery disease 13 4
Renal insufficiency 5 1
COPD 22 6
Medical treatment
Antiplatelet 22 6
Anticoagulant 3
Statins 10 3
COPD, Chronic obstructive pulmonary disease.
Table II. Anatomical features in 74 patients
Group
N
Iliac aneurysm diameter (mm) 40.2
Bilateral iliac aneurysm 4
Abdominal aortic aneurysm  3.5 cm 25
Internal iliac aneurysm 6IIA branch and IIA stent required another interpositionendograft placement. Early reintervention was performed
in two patients (5%) of Group II , one for limb ischemia and
the other for femoral wound dehiscence.
The 30-day follow-up CT examination revealed a type
2 iliac endoleak in nine patients, eight in Group II, refilled
from IIA branch (Table III). None of these type 2 early
endoleaks was treated.
Mean follow-up was 9.8 months in Group I (range,
1-24 months) and 31.1 months (range, 1-74 months) in
Group II (P  .001), reflecting the younger adoption of
IBD technique in our center. To obtain comparable results
in the two groups, we report here the 12-month results
regarding 23 patients in Group I and 37 patients in Group
II (Table IV). Overall mortality at one year was 4% in
Group I and 7% in Group II, all due to unrelated causes:
one patient with IBD died of myocardial infarction two
months after the operation; in Group II, the three deaths
were caused by oesophageal cancer, bleeding gastric ulcer,
and respiratory failure.
Iliac aneurysm significantly (at least 5 mm) decreased in
diameter, in seven patients in Group I (30%) and in 13
(34%) in Group II (P .8). Only one patient, in Group II,
experienced iliac aneurysm growth, of 5 mm, due to hypo-
gastric incomplete exclusion and type 2 endoleak (Fig 2),
requiring successful secondary coil embolization through
contralateral hypogastric super-selective catheterization. At
one year, type 2 endoleak was present in eight iliac aneu-
rysms (13.3%), all but one in Group II. The difference was
Group II  42
PN %
39 93 1
76.2  6.7 .1
27 64 .6
36 86 .7
2 5 .6
11 26 1
25 59 .2
4 10 .5
27 64 .8
39 92 .01
2 5 .6
6 14 .9
2 Group II  42
P% N %
38.4  10.8 .4
12 4 9 .7
78 36 86 .5
19 14 34 .2%
4
6
1
9
8
1
6
9
9
9
2I  3
 7.9not statistically significant (P  .13). Besides the one
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endoleak received secondary treatment. Endoleak origin
was clearly identified in six patients in Group II: in four with
Table III. Perioperative results (30 days)
Group I  32
N
Mortality/rupture 0
Procedure time (min) 153
Fluoro time (min) 45  23
Contrast (cc) 182  35
Technical failure 2
External iliac limb occlusion 2
Iliac endoleak 1
Reintervention 5
Local complications 2
Pseudoaneurysm 1
Wound dehiscence –
Wound hemorrhage 1
Lymphorrea –
Table IV. One-year results
Patients
Group
I  23
Group
II  37
PN % N %
Unrelated mortality 1 4 3 7 1
Reinterventions 0 – 2 5 .1
Iliac endoleak 1 4 7 19 .1
Pelvic ischemia* 1 4 8 22 .1
Iliac diameter decrease 7 30 13 35 .8
Iliac limb occlusion 0 – 1 3 1
*Including the combination of bowel, spinal cord, nerve ischemia, sexual
impotence, buttock or thigh claudication, and buttock necrosis.
Fig 2. Abdominal 3-D computerized tomography reconstruction
after aorto-bi-iliac endografting and right hypogastric coil emboliza-
tion. With * a type 2 iliac endoleak is indicated, while # indicates the
coils deployed at the distal end of the hypogastric aneurysm.IIA aneurysm, coils were deployed in only one of theterminal branches of the IIA, leaving other branches patent
and responsible for back filling into the aneurysm. In
another one, the type 2 endoleak originated through a
communication with patent inferior mesenteric artery,
while in the last, refilling was due to the lack of successful
IIA coil embolization. In other two cases, one in each
group, a tiny endoleak resulted from unclear origin.
None of the IBD limbs occluded during follow-up.
Limb occlusion occurred in one patient in Group II, eight
months after the original procedure and required a femoro-
femoral crossover by-pass, leading to a one-year reinterven-
tion rate of 5.4% in Group II, while no secondary proce-
dures had been performed in patients in Group I (P  .1).
Prevalence of pelvic ischemic signs was higher in patients in
Group II compared with Group I, 22% (eight patients)
versus 4% (one patient), respectively, the difference not
being statistically significant (P  .1). In patients with IIA
embolization, buttock claudication was present in five pa-
tients with a single IIA occlusion, in one with IIA occlusion
and contralateral patent EIA to IIA bypass, and in one with
bilateral IIA occlusion after a failed IIA revascularization.
One patient with single IIA occlusion complained of a new
onset of sexual impotence, persisting at 12 months. In
Group I, only one patient with a patent IBD and contralat-
eral IIA occlusion complained of persisting buttock claudi-
cation at 12 months.
DISCUSSION
Proper management of iliac aneurysms has not been
completely standardized. Since several reports documented
the utility of endovascular approach, a number of endovas-
cular techniques have been applied either preserving (bell
bottom, transposition/bypass, external to internal en-
dografting) or sacrificing (simple coverage, coil emboliza-
tion of hypogastric artery) hypogastric flow.11-14 Despite
good midterm results, with low morbidity/mortality rates,
a number of drawbacks, such as endoleak, disconnection,
iliac occlusion, and risk of pelvic ischemia are still unsolved
issues, limiting the generalization of the procedures. Cur-
Group II  42
PN %
0
160 .02
31  14 .02
180  42 .8
3 7 1
2 5 1
8 19 .07
2 5 .2
3 7 1
– – –
1 2 –
– – –
2 5 –%
6
6
3
16
6
2
–
3rently, the first choice for endovascular treatment of iso-
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of the hypogastric artery and extension of the endograft
into the EIA. However, literature data show that approxi-
mately one-third of patients with hypogastric occlusion
have symptoms of pelvic ischemia: buttock claudication is
fortunately the most common, occurring in about 80% of
symptomatic patients, with impotence in about 10% and
colonic ischemia in 6% to 9% of all the pelvic ischemic
complications.15-23 Although most of these complications
may be benign and may improve with time, severe colon
ischemia resulting in death has been described.17,21
The IBD is a new device that offers the possibility of
preserving antegrade hypogastric artery flow in patients
with aortoiliac aneurysms during endovascular repair. Here
we present the first report comparing coil embolization
with IBD approach in a contemporary series of patients.
Our results suggest that a vast majority of patients can
be successfully treated with this device without complica-
tions both in the perioperative period and in the mid-term.
At 12-month follow-up, only two patients (6%) had IIA
occlusion after IBD and only one patient (4%) complained
of buttock claudication, because of the planned IIA occlu-
sion contralateral to a patent IBD. Conversely, after IIA
embolization, a higher incidence of buttock claudication is
to be expected (22% in our experience), with invalidating
symptoms even after one year.
These figures are similar to those recently reported by
Farahmand et al who investigated the outcomes of 101
patients with either IIA embolization (n  76) or simple
IIA ostium coverage (n 25). They found an incidence of
buttock claudication of 50% after EVAR that did not im-
prove with time in 33%; sexual dysfunction occurred in
19.6% of patients without any improvement during follow-
up. The authors also underlined the higher risk of symp-
toms in deep deployment of coils into the IIA ramifications
and in patients with left ventricular dysfunction.4
These findings bring to discussion the possible exten-
sive indication to IBD in patients with unilateral IIA aneu-
rysm involvement and eventual use of dual IBDs in patients
with bilateral IIA aneurysms. Results of these approaches
and cost effective analyses have not been fully evaluated yet,
but the rationale to preserve both IIA to avoid invalidating
symptoms appears to justify an aggressive posture toward
IBD use at least in cases of younger patients with active
lifestyles.
In our experience, both the IBD procedure and coil
hypogastric embolization with EIA extension were effec-
tive in the medium term, because no patients had persistent
type 1 endoleak, junction endoleak, or bowel ischemia.
However, some advantages were observed in the IBD
Group procedure, including only one case of occurrence of
buttock claudication, no impotence (vs one in Group II
after coil embolization), and only one type 2 endoleak (vs
20% from hypogastric reperfusion in Group II). These data
could suggest that IBD is more effective in both ensuring
distal sealing with aneurysm exclusion and preserving ade-
quate pelvic flow. However, more robust data are needed
to confirm this hypothesis.Despite the apparent increased complexity of IBD with
respect to coil embolization, there were no higher periop-
erative failure rates. There were two unsuccessful deploy-
ments of IBD in Group I, with immediate intraoperative
occlusion of the hypogastric side branch, and three failures
to coil or complete the procedures in Group II. In both
groups, main reasons of failure were severe iliac artery
tortuosity and calcification; these anatomic features still
representing exclusion criteria for endovascular approach.
Of relevance, the two intraoperative occlusions of hypogas-
tric side branch in Group I were entirely asymptomatic and
did not require adjunctive treatment. At the same time, the
occluded device was still able to ensure adequate distal
sealing and prevent reperfusion (no type 2 endoleak, no
disconnection). Therefore, when comparing the IBD tech-
nique with embolization and covering of the hypogastric
origin, an additional advantage is that there is nothing to be
lost if the side branch occludes when using IBD.
In our series, no occlusion of the hypogastric branches
were detected during follow-up after successfully com-
pleted procedure. This was not the case in other experi-
ences, where longer follow-up reported the results of older
generation IBD together with the current version. Ziegler
et al, reviewing a five-year experience with IBD in 46
patients, reported technical success of only 58% in older
version IBD, while for the second generation device, the
same used in our experience, it reached 85%. During follow-
up, 11% of IBD (4/35) showed hypogastric branch occlu-
sion, all within the first 12 months, but without significant
differences between the two device generations.7
Long-term results of dilated iliac arteries treated by
endovascular route are not yet fully understood. According
to our data, one year after endovascular repair, iliac aneu-
rysm shrinks in about 30% and secondary intervention may
be necessary in 5%-16% regardless of the technique used.
However, unlike for AAA, the natural history of iliac aneu-
rysm is not well defined and the true incidence of rupture
and its correlation with size is still unclear, with earlier series
reporting rates of 14% to 70%.24 Given the unclear natural
history of these aneurysms and the higher rate of morbidity
in the setting of emergent repair (even with endovascular
techniques), patients with favorable anatomy should be
repaired by endovascular route.
The Achilles heel of all endograft landings into the EIA
is always the risk of late occlusions due to graft kinkings at
the level of iliac tortuosities. In our experience, external
iliac occlusion occurred in two cases of IBD, where the
hypogastric branch was patent in one case and occluded in
the second. Both were successfully managed by thrombec-
tomy and additional stenting to give more support to the
endograft limb, but this underlines the need for careful
evaluation of any residual angulation at the end of the
procedure and the liberal use of additional stents to prevent
graft kink. Houlon et al reported three cases of external iliac
occlusion in 52 patients with helical IBD, occurring in the
non-branched side in two cases and in the IBD side in one
case after occlusion of the hypogastric branch.5 They pos-
tulated that the increased flow in the side of a patent IBD
JOURNAL OF VASCULAR SURGERY
May 20091160 Verzini et alcould prevent thrombosis of the external iliac limb, but this
hypothesis failed at least once in one of our patients. We
believe that any graft angulation, especially at the origin of
the EIA, can be sufficient to provoke a later occlusion, and
in any case of suspicion of graft kink after removing the
guidewire at the end of the procedure, we now confirm the
absence of flow limitation by measuring the pressure gradi-
ent immediately above and below the graft curvature, and
liberally place additional bare stents.
In this study, no late external iliac artery occlusions
occurred after the first month, confirming the importance
of careful evaluation of the intraoperative technical result.
However, other experiences with IBD reported occlusions
of the external limb of the IBD that were detected at later
times. Dias et al reported two late external iliac occlusions
in 22 patients with IBD, occurring at four and six months,
both determined by kinking of the graft. Malina et al, from
the same group, underlined that one (10%) late occlusion
of the EIA (at six months) on the side of a patent hypogas-
tric branch, remained asymptomatic without adjunctive
treatment.9,25
Our results were not provided by a randomized compar-
ison. Small sample size, limited follow-up, lack of cost-benefit
analyses, as well as lack of standardized questionnaire and
objective criteria to assess impotence (eg, penile-brachial in-
dex) are other limitations of this preliminary experience with
IBD.
In conclusion, the use of IBD in maintaining antegrade
flow to at least one hypogastric artery for aortoiliac aneu-
rysm repair is feasible and safe. Careful patient selection and
exclusion of those presenting excessive iliac tortuosity and
deep aneurysmal involvement of the hypogastric artery are
the keys to technical success. When compared with hypo-
gastric embolization, the IBD approach presents fewer
symptoms of pelvic ischemia and endoleaks. Moreover,
there is nothing to be lost if the side branch occludes,
producing the same effect of hypogastric embolization.
Longer term follow-up and larger studies are needed to
confirm these suggestions.
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